PlatoX™ delivers a market place for genetic testing that connects diagnostic laboratories and medical professionals to enable personalized medicine based on all worldwide available state-of-the-art genetic tests.
Upon global launch of the platform the total addressable market is estimated at € 27 billion in 2022. Platomics will use genetic testing as a proof-of-concept market and has the ambition to extend its service to general diagnostics for healthcare and the lifestyle market in the future.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it :)Yeah, OkRead more
